Sign in
4

Changes in Ownership

Summit Therapeutics Inc. Filed Acc 0000921895-21-001335

Chief Executive Officer bought 11,365,921 shares at $5.24 ($59,557,426)

From the SEC's structured data for this filing

Trades in this filing

DUGGAN ROBERT W · Chief Executive Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-12 Purchase : show line 1 in the form +11,365,921 $5.24 $59,557,426 67,662,454 D
Open-market purchases · 11,365,921 sh · avg $5.24 · $59,557,426
Loading xslF345X03/form412566dug_05142021.xml…